文献速递血脂与心血管预防

利用超百万献血者的血液筛查项目识别家族性高胆固醇血症

Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors.
PubMed 文献 · JAMA Cardiol · 2019-01-01

该研究分析了2002至2016年间美国Carter BloodCare的1 178 102名献血者数据,采用MEDPED通用人群标准定义家族性高胆固醇血症。结果显示每339名献血者中约有1人符合标准,年轻人群及男性患病率更高,提示献血筛查可作为识别潜在家族性高胆固醇血症的新策略。

要点

  • 献血者中家族性高胆固醇血症的患病率约为1:339,与普通人群估计相似。
  • 年轻献血者(<30岁)患病率高于年长者(≥30岁),男性高于女性。
  • 献血筛查项目可能有助于早期发现家族性高胆固醇血症并指导级联筛查。

核心结论

  • 在大型献血者队列中,采用MEDPED通用人群标准定义的家族性高胆固醇血症患病率与普通人群估计相似。
  • 献血者筛查项目可能成为检测并通知潜在家族性高胆固醇血症个体的新策略,尤其有助于年轻个体的早期发现和治疗。

研究设计与样本

  • 研究分析了2002年1月至2016年12月期间向美国Carter BloodCare献血的所有16岁及以上献血者的去标识化数据。
  • 家族性高胆固醇血症采用MEDPED通用人群标准定义,不同年龄组的总胆固醇阈值分别为:<20岁270 mg/dL、20-29岁290 mg/dL、30-39岁340 mg/dL、≥40岁360 mg/dL。
  • 对于重复献血者,分析中使用观察到的最大总胆固醇水平。

主要发现

  • 研究共纳入1 178 102名个体献血者,总计3 038 420次献血。
  • 所有个体献血者的中位总胆固醇为183 mg/dL(IQR 157-212),中位年龄32岁(IQR 19-47),女性619 583人(52.6%)。
  • 共有3473人(即每339人中1人)符合家族性高胆固醇血症标准,该组中位总胆固醇为332 mg/dL(IQR 297-377)。
  • 估计患病率在年轻年龄组更高(<30岁:1:257)相比年长组(≥30岁:1:469;P < .001),男性(1:327)高于女性(1:351;P = .03)。
  • 在2219名至少一次符合家族性高胆固醇血症标准的重复献血者中,其10 833次总献血中有3116次(28.8%)符合家族性高胆固醇血症标准。

关键数值与推荐

  • 家族性高胆固醇血症定义采用MEDPED通用人群标准,总非空腹血清胆固醇阈值按年龄分层:<20岁270 mg/dL、20-29岁290 mg/dL、30-39岁340 mg/dL、≥40岁360 mg/dL。

临床怎么用

  • 献血筛查项目可作为识别潜在家族性高胆固醇血症个体的新策略,尤其适用于年轻人群的早期检测。
  • 对筛查发现的潜在患者应进行通知,并指导级联筛查以识别家族成员。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Familial hypercholesterolemia is an autosomal-dominant disorder that often causes premature coronary artery disease. Unfortunately, familial hypercholesterolemia remains largely undiagnosed. OBJECTIVE: To estimate the prevalence of familial hypercholesterolemia in a population of blood donors. DESIGN: This analysis of deidentified data from blood donors 16 years and older who donated to Carter BloodCare, one of the largest independent blood programs in the United States, between January 2002 and December 2016. Carter BloodCare, which serves a population of about 8 million in Texas, routinely measures total nonfasting serum cholesterol levels as part of a donor health screening program. Data analysis occurred from October 2017 to March 2019. EXPOSURE: Blood donation. MAIN OUTCOMES AND MEASURES: Familial hypercholesterolemia was defined using the Make Early Diagnosis to Prevent Early Death general population criteria, with total nonfasting serum cholesterol thresholds of 270, 290, 340, and 360 mg/dL for donors younger than 20 years, 20 to 29 years, 30 to 39 years, and 40 years or older, respectively (to convert cholesterol values to mmol/L, multiply by 0.0259). For repeated donors, the maximum observed total cholesterol level was used for analyses. RESULTS: The study included 1 178 102 individual donors with a total of 3 038 420 blood donations. Of all individual donors (median total cholesterol level, 183 [interquartile range (IQR), 157-212] mg/dL; median age, 32 [IQR, 19-47] years; 619 583 [52.6%] women), a total of 3473 individuals (or 1 in every 339) met criteria for familial hypercholesterolemia. This group had a median (IQR) total cholesterol of 332 (297-377) mg/dL. Estimated prevalence was higher at younger ages (<30 years: 1:257) compared with older ages (≥30 years: 1:469; P < .001) and in men (1:327) compared with women (1:351; P = .03). Among 2219 repeated donors who met familial hypercholesterolemia criteria at least once, 3116 of 10 833 total donations (28.8%) met FH criteria. CONCLUSIONS AND RELEVANCE: The prevalence of familial hypercholesterolemia using the Make Early Diagnosis to Prevent Early Death criteria in a large cohort of blood donors was similar to the estimated prevalence of this disorder in the general population. The blood donor screening program could be a novel strategy to detect and notify individuals with potential familial hypercholesterolemia, particularly younger individuals in whom early detection and treatment is especially helpful, as well as guide cascade screening.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Jackson CL, Keeton JZ, Eason SJ, et al. Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors. JAMA Cardiol. 2019. PMID: 31116347. doi:10.1001/jamacardio.2019.1518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。